Levodopa/Carbidopa Fairmed Healthcare (Carbidopa, Levodopa)

Levodopa/Carbidopa, the active ingredient in Levodopa/Carbidopa Fairmed Healthcare, is a dopamine precursor / dopa decarboxylase inhibitor combination presented as an oral tablet for oral use. It is indicated for the management of Parkinson's disease and related Parkinsonian syndromes, helping to restore deficient central dopamine levels.

GNH USA supplies Levodopa/Carbidopa Fairmed Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution across multiple continents.

Levodopa/Carbidopa acts on the dopaminergic pathway to improve motor function in Parkinsonian disorders.

- Parkinson's disease: reduces motor symptoms such as bradykinesia, rigidity, and tremor, improving daily functioning. - Parkinsonian syndrome: alleviates movement impairments caused by secondary or atypical Parkinsonism. - Motor fluctuations in Parkinson's disease: smooths out “off” periods and enhances overall motor control.

Levodopa/Carbidopa may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Vomiting - Dizziness - Headache - Orthostatic hypotension

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Psychosis or hallucinations - Severe hypotension leading to fainting - Cardiac arrhythmias - Neuroleptic malignant syndrome - Anaphylactic reaction

When prescribing Levodopa/Carbidopa, clinicians should observe several safety considerations.

- Monitor blood pressure: watch for orthostatic hypotension, especially during dose titration. - Assess psychiatric status: be alert for hallucinations or worsening psychosis. - Adjust dose in renal impairment: consider reduced clearance and possible accumulation. - Avoid abrupt discontinuation: sudden stop may precipitate worsening motor symptoms. - Store at room temperature: keep in original container, protect from moisture and light.

Levodopa/Carbidopa can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - MAO‑B inhibitors: risk of hypertensive crisis when combined. - Antipsychotics: may block dopamine receptors and reduce therapeutic effect. - Antihypertensives: additive orthostatic hypotension, increasing fall risk.

Moderate Interactions (Monitor Closely): - High‑protein meals: decrease levodopa absorption, potentially reducing efficacy. - Iron or vitamin C supplements: may bind levodopa in the gut and lower its bioavailability. - SSRIs: monitor for possible serotonin syndrome when used together.